0001062993-23-011116.txt : 20230515 0001062993-23-011116.hdr.sgml : 20230515 20230515163301 ACCESSION NUMBER: 0001062993-23-011116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230511 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stecyk Chrystyna Bedrij CENTRAL INDEX KEY: 0001811625 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38624 FILM NUMBER: 23923267 MAIL ADDRESS: STREET 1: 1895 MT. HOPE AVENUE CITY: ROCHESTER STATE: NY ZIP: 14620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VACCINEX, INC. CENTRAL INDEX KEY: 0001205922 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 161603202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1895 MOUNT HOPE AVE CITY: ROCHESTER STATE: NY ZIP: 14620 BUSINESS PHONE: 585-271-2700 MAIL ADDRESS: STREET 1: 1895 MOUNT HOPE AVE CITY: ROCHESTER STATE: NY ZIP: 14620 FORMER COMPANY: FORMER CONFORMED NAME: VACCINEX INC DATE OF NAME CHANGE: 20021114 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0407 4 2023-05-11 0001205922 VACCINEX, INC. VCNX 0001811625 Stecyk Chrystyna Bedrij C/O VACCINEX, INC. 1895 MOUNT HOPE AVENUE ROCHESTER NY 14620 1 0 0 0 0 Stock Option (Right to Buy) 3.95 2021-05-14 Common Stock 25087 25087 D Stock Option (Right to Buy) 2.15 2022-05-11 Common Stock 28586 28586 D Stock Option (Right to Buy) 1.12 2023-05-12 Common Stock 53254 53254 D Stock Option (Right to Buy) 0.41 2023-05-11 4 A 0 143848 0 A 2024-05-11 Common Stock 143848 143848 D This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first. This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first. This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first. This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first. /s/ Scott E. Royer, Attorney-in-Fact for Chrystyna Bedrij Stecyk 2023-05-15